Factors associated with willingness to take extended release naltrexone among injection drug users

BACKGROUND: Although opioid-agonist therapy with methadone or buprenorphine/naloxone is currently the mainstay of medical treatment for opioid use disorder, these medications often are not well accepted or tolerated by patients. Recently, extended release naltrexone (XR-NTX), an opioid antagonist, h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Addict Sci Clin Pract
Main Authors: Ahamad, Keith, Milloy, MJ, Nguyen, Paul, Uhlmann, Sasha, Johnson, Cheyenne, Korthuis, Todd P, Kerr, Thomas, Wood, Evan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636793/
https://ncbi.nlm.nih.gov/pubmed/25935714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13722-015-0034-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados